Wednesday, April 22, 2009

"Price Controls On Prescription Drugs Could Have Adverse Effect On Life Spans, Study Says"

Ready for the kicker? If you read down to the bottom, it suggests that "a better approach to moderating prescription drug prices would be to cut drug insurance copayments by 20%, which by 2060 would increase life expectancy in the U.S. by half a year because more people would take needed drugs and drug industry profits would motivate further innovation."
And where exactly do they think this loss in copayment monies is going to be subsequently recouped? Ahh, right, by the consumers, who, will instead of paying this 20% "out-of-pocket," will lose it directly from their paycheck.

No comments:

Post a Comment

Followers